ATLASKrystal Biotech (KRYS) earnings date: Nov 2, 2026
Krystal Biotech (KRYS) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, before the open. Analysts expect EPS of $1.84.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KRYS
| Last price | $332.29 (+2.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.2% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Krystal Biotech stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Krystal Biotech reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Krystal Biotech. You can switch it off at any time.
Alert me before KRYS reportsFree to start. Creating an account takes under a minute.
KRYS earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $1.84 |
| Last report | Aug 28, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +37.6% |
| Average move around a report | ±3.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Krystal Biotech earnings history: last 5 reports
Krystal Biotech last reported on Aug 28, 2026: EPS of $0.56 against an estimate of $0.51 (+9.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 28, 2026 | $0.51 | $0.56 | +9.8% | Beat | +0.5% |
| Aug 3, 2026 | $1.91 | $1.79 | -6.3% | Miss | -4.8% |
| May 4, 2026 | $1.42 | $1.83 | +28.9% | Beat | +7.0% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | -1.3% |
| Feb 17, 2026 | $1.61 | $1.70 | +5.6% | Beat | +2.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KRYS
See the fair value, the probability range and the earnings history of Krystal Biotech on its ATLAS page.
Krystal Biotech (KRYS) stock analysisPlans from €3.99 a month.
Krystal Biotech earnings: frequently asked questions
When does Krystal Biotech (KRYS) report earnings?
Krystal Biotech is scheduled to report on Monday, November 2, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for KRYS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $1.84 per share (USD). Estimates can change before the report.
How often does KRYS beat earnings estimates?
Of its last 5 reports with a recorded result, Krystal Biotech beat the EPS estimate 4 times; the average surprise was +37.6%. Past results do not predict the next one.
How much does KRYS move around earnings?
Over its last 5 reports the stock moved an average of 3.2% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Krystal Biotech beat earnings estimates last quarter?
Krystal Biotech last reported on Aug 28, 2026: EPS of $0.56 against an estimate of $0.51 (+9.8% surprise), a beat.
How much does KRYS usually move in a day?
On a normal trading day the ATLAS model puts KRYS’s one-day range at about ±2.2%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer